Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioVie Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BIVI
Nasdaq
8731
https://www.bioviepharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioVie Inc
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
- Apr 18th, 2024 12:00 pm
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- Apr 12th, 2024 1:00 pm
Bears are Losing Control Over BioVie Inc. (BIVI), Here's Why It's a 'Buy' Now
- Mar 12th, 2024 1:55 pm
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
- Mar 11th, 2024 12:00 pm
BioVie Inc. Announces Closing of Public Offering
- Mar 6th, 2024 10:00 pm
BioVie Inc. Announces Pricing of Public Offering
- Mar 4th, 2024 6:32 am
BioVie Inc. Announces Proposed Public Offering of Common Stock
- Mar 1st, 2024 9:58 pm
BioVie Inc. Announces Proposed Public Offering of Common Stoc
- Mar 1st, 2024 9:58 pm
BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024
- Mar 1st, 2024 1:00 pm
BioVie to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 6th, 2024 1:00 pm
18 Best 52-Week Low Stocks To Buy Now
- Jan 27th, 2024 10:29 am
bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
- Jan 5th, 2024 2:00 pm
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
- Dec 29th, 2023 2:00 pm
Rail Vision and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
- Dec 22nd, 2023 2:00 pm
BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Dec 11th, 2023 2:35 pm
The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
- Dec 1st, 2023 10:09 am
Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
- Nov 30th, 2023 3:33 pm
BioVie (BIVI) Falls 61% Despite Upbeat Alzheimer's Study Data
- Nov 30th, 2023 3:20 pm
BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s Disease
- Nov 29th, 2023 1:00 pm
BioVie Presents Positive Clinical Safety Data from Phase 2b Trial of BIV201 in Refractory Ascites at the American Association for the Study of Liver Disease (AASLD) - The Liver Meeting® 2023
- Nov 13th, 2023 1:00 pm
Scroll